{
"id":"mk19_a_id_t02",
"number":2,
"bookId":"id",
"title":{
"__html":"Treatment of Bacterial Meningitis"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"a12a03",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 2. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_id_t02"
}
]
},
"Treatment of Bacterial Meningitis"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3625cf",
"class":"col hd l",
"children":[
"Clinical Characteristics"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7b08ca",
"class":"col hd l",
"children":[
"Empiric Antibiotic Regimen",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9998eb",
"class":"cell txt l",
"children":[
"Immunocompetent host age ≤50 y with community-acquired bacterial meningitis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cd4c05",
"class":"cell txt l",
"children":[
"IV ceftriaxone ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"or"
]
},
" cefotaxime plus IV vancomycin"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3f1b89",
"class":"cell txt l",
"children":[
"Age >50 y or those with altered cell-mediated immunity"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e2ca30",
"class":"cell txt l",
"children":[
"IV ampicillin (",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Listeria"
]
},
" coverage), plus IV ceftriaxone ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"or"
]
},
" cefotaxime, plus IV vancomycin",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
" "
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f5fa88",
"class":"cell txt l",
"children":[
"Allergies to β-lactams"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ee70b9",
"class":"cell txt l",
"children":[
"IV moxifloxacin instead of cephalosporin"
]
},
" ",
{
"type":"p",
"hlId":"af9ead",
"class":"cell txt l",
"children":[
"IV trimethoprim-sulfamethoxazole instead of ampicillin"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4229f5",
"class":"cell txt l",
"children":[
"Health care–associated ventriculitis or meningitis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7dc2c6",
"class":"cell txt l",
"children":[
"IV vancomycin plus either IV ceftazidime, cefepime, or meropenem"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"IV = intravenous; U.S. = United States."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Adjunctive dexamethasone should be given concomitantly with the first dose of antibiotic therapy and should be continued for 4 days in patients with ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Streptococcus pneumoniae"
]
},
" meningitis and stopped in all others."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"In countries with ceftriaxone resistance rate >1%, such as the United States."
]
]
}